Renhuang Pharmaceuticals, located in Harbin of Heilongjiang Province in Northeast China, is a leading integrated developer, manufacturer and distributor of a broad line of high-quality nutraceutical, natural medicinal and bio-pharmaceutical products. The Company provides three major product lines including the Acanthopanax-based natural medicinal products, Shark Power Health Care series (a natural marine biological product) and Traditional Medical Products. Renhuang's key product line is Acanthopanax-based products, an effective natural medicine in treating depression and melancholy. By controlling an estimated 70% of China's natural resource of Acanthopanax (also known as Siberian Ginseng), the Company possesses a unique competitive edge and therefore occupies a dominant market position in Acanthopanax-based natural anti-depressant. The Company distributes its products through a multi-layer sales network of over 2000 sales agents. Its products are not only sold nationwide but also exported to Russia and Southeast Asia.

Renhuang has established a multi-channel research and development infrastructure composed of in-house researchers, a post-doctoral working center, and collaboration with well known institutions and scientists. The Company has achieved a significant progress in research & development of standard extraction, separation of effective components, and medication with specificity. Several of these products have already been submitted for approval by the State Food and Drug Administration ("SFDA"). These products are expected to have a substantial upside growth potential due to their insufficient supply in China. In manufacturing, the Company strictly follows the international GMP certified quality processes and system by utilizing cutting-edge technologies, the state of the art equipment, and the proprietary innovative and award winning processes.